» Articles » PMID: 34662671

Ultrasonic Particles: An Approach for Targeted Gene Delivery

Overview
Specialty Pharmacology
Date 2021 Oct 18
PMID 34662671
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Gene therapy has been widely investigated for the treatment of genetic, acquired, and infectious diseases. Pioneering work utilized viral vectors; however, these are suspected of causing serious adverse events, resulting in the termination of several clinical trials. Non-viral vectors, such as lipid nanoparticles, have attracted significant interest, mainly due to their successful use in vaccines in the current COVID-19 pandemic. Although they allow safe delivery, they come with the disadvantage of off-target delivery. The application of ultrasound to ultrasound-sensitive particles allows for a direct, site-specific transfer of genetic materials into the organ/site of interest. This process, termed ultrasound-targeted gene delivery (UTGD), also increases cell membrane permeability and enhances gene uptake. This review focuses on the advances in ultrasound and the development of ultrasonic particles for UTGD across a range of diseases. Furthermore, we discuss the limitations and future perspectives of UTGD.

Citing Articles

Harnessing stimuli-responsive biomaterials for advanced biomedical applications.

Liao Z, Liu T, Yao Z, Hu T, Ji X, Yao B Exploration (Beijing). 2025; 5(1):20230133.

PMID: 40040822 PMC: 11875454. DOI: 10.1002/EXP.20230133.


Ultrasound-targeted sirolimus-loaded microbubbles improves acute rejection of heart transplantation in rats by inhibiting TGF-β1-Smad signaling pathway, promoting autophagy and reducing inflammation.

Bao H, Dai L, Wang H, Jiang T Int J Pharm X. 2024; 8:100300.

PMID: 39624342 PMC: 11609676. DOI: 10.1016/j.ijpx.2024.100300.


Polydopamine Nanobowl-Armoured Perfluorocarbon Emulsions: Tracking Thermal- and Photothermal-Induced Phase Change through Neutron Scattering.

Vidallon M, Liu H, Lu Z, Acter S, Song Y, Baldwin C Small. 2024; 21(2):e2406019.

PMID: 39523733 PMC: 11735900. DOI: 10.1002/smll.202406019.


Engineering Hyperechogenic Colloids with Clot-Targeting Capabilities from Platelet-Derived Membranes.

Vidallon M, Moon M, Liu H, Song Y, Crawford S, Teo B ACS Appl Mater Interfaces. 2024; .

PMID: 39360874 PMC: 11492166. DOI: 10.1021/acsami.4c12024.


2D spatiotemporal passive cavitation imaging and evaluation during ultrasound thrombolysis based on diagnostic ultrasound platform.

Zhang Q, Zhu Y, Zhang G, Xue H, Ding B, Tu J Ultrason Sonochem. 2024; 110:107051.

PMID: 39232288 PMC: 11404082. DOI: 10.1016/j.ultsonch.2024.107051.


References
1.
Akinc A, Maier M, Manoharan M, FitzGerald K, Jayaraman M, Barros S . The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs. Nat Nanotechnol. 2019; 14(12):1084-1087. DOI: 10.1038/s41565-019-0591-y. View

2.
Wang X, Niu D, Hu C, Li P . Polyethyleneimine-Based Nanocarriers for Gene Delivery. Curr Pharm Des. 2015; 21(42):6140-56. DOI: 10.2174/1381612821666151027152907. View

3.
De Temmerman M, Dewitte H, Vandenbroucke R, Lucas B, Libert C, Demeester J . mRNA-Lipoplex loaded microbubble contrast agents for ultrasound-assisted transfection of dendritic cells. Biomaterials. 2011; 32(34):9128-35. DOI: 10.1016/j.biomaterials.2011.08.024. View

4.
Skyba D, Price R, Linka A, Skalak T, Kaul S . Direct in vivo visualization of intravascular destruction of microbubbles by ultrasound and its local effects on tissue. Circulation. 1998; 98(4):290-3. DOI: 10.1161/01.cir.98.4.290. View

5.
Wang X, Palasubramaniam J, Gkanatsas Y, Hohmann J, Westein E, Kanojia R . Towards effective and safe thrombolysis and thromboprophylaxis: preclinical testing of a novel antibody-targeted recombinant plasminogen activator directed against activated platelets. Circ Res. 2014; 114(7):1083-93. DOI: 10.1161/CIRCRESAHA.114.302514. View